Please login to the form below

Not currently logged in
Email:
Password:

Fresenius Kabi Oncology

This page shows the latest Fresenius Kabi Oncology news and features for those working in and with pharma, biotech and healthcare.

Two blood cancer drugs among CHMP recommendations

Two blood cancer drugs among CHMP recommendations

The CHMP also granted positive opinions to Fresenius' generic version of the chemotherapy busulfan and to a biosimilar version of Amgen's Neupogen to be marketed by Accord. ... The final recommendation was for a generic version of busulfan to be marketed

Latest news

  • GSK loses patent on Tykerb in India GSK loses patent on Tykerb in India

    A bid to overturn the patent - filed by New Delhi-based Fresenius Kabi Oncology Ltd - was upheld by India's Intellectual Property Appellate Board (IPAB) last week, opening the door to

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Star

We're passionate about helping our clients to make a real commercial impact. We achieve this through our unique approach to...

Latest intelligence

Report: Achieving launch excellence in the challenging healthcare markets of today
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...
What is blockchain and why should i care - Richard Springham
Four Health - Emerging Technologies The power of blockchain lies in the fact it can prove that a unique event occurred at a certain time with out the need to...
NHS medicines optimisation milestone
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare Consulting Team, explore the implications of Adalimumab’s recent European patent expiry...

Infographics